ALKS 3831, if approved by the FDA, could be a promising new treatment option for schizophrenia or bipolar I disorder.
Adam Simmons, MPH
Advertisement
Articles by Adam Simmons, MPH
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Psychiatric Times
1
Trick or Treat: Fiddling While Rome Burns or Playing a Violin of Hope?
2
“Porosity”: Connecting 2 Western Cultural Psychiatric Discourses in Tokyo by Way of Naples
3
Positive FDA Meeting for Abuse Deterrent Fentanyl Patch
4
The Dangers of Conversion Therapy: What Chiles v Salazar Could Mean for LGBTQ+ Youth
5
